De La Torre M., Urra J., Blanco J.Raised expression of cytokine receptor gp130 subunit on peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease activity?Lupus2009; 18: 216-222.
2.
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271-1277.
3.
Weening JJ, D’agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol2004; 15: 241-250.
4.
Gladman DD, Ibanez D., Urowitz MBSystemic lupus erythematosus disease activity index 2000. J Rheumatol2002; 29: 288-291.
5.
Memoli B., Grandaliano G., Soccio M., et al. In vivo modulation of soluble ‘‘antagonistic’’ IL-6 receptor synthesis and release in ESRD. J Am Soc Nephrol2005; 16: 1099-1107.
6.
Horii Y., Iwano M., Hirata E., et al. Role of interleukin-6 in the progression of mesiangial proliferative glomerulonephritis. Kidney Int Suppl1993; 39: S71-S75.
7.
Sabry A., Sheashaa H., El-Husseini A., et al. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine2006; 35: 148-153.
8.
Barcellini W. , Rizzardi GP, Borghi MO, et al. In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity. Lupus1996; 5: 139-145.
9.
Gröndal G., Gunnarsson I., Rönnelid J., Rogberg S., Klareskog L., Lundberg I.Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol2000; 18: 565-570.
10.
Jones BM, Liu T., Wong RWReduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. Autoimmunity1999; 31: 117-124.
